Strategy of early screening for active pulmonary tuberculosis in general hospital

doi:10.19983/j.issn.2096-8493.20220078

Abstract

Abstract:

Tuberculosis has long been considered a big theat in China. Preventing and controlling tuberculosis is a continuous effort, yet the situation is still not optimistic. We emphasize the urgent need for active pulmonary tuberculosis (APTB) as a screening strategy to find tuberculosis in general hospitals. In this review, we first provide an introduction to APTB. Then, we quantitively compare APTB with other tuberculosis examinations, which demonstrates the advantages of APTB. Finally, we provide detailed analysis on the differences between screening strategies in inpatient and outpatient departments. Our work is a crucial reference for applying APTB as a tuberculosis screening strategy in general hospitals.

Key words: Tuberculosis, pulmonary, Early diagnosis, Hospitals, general, Sanitation

CLC Number:

R521
R81

He Yanchao, Jie Zhijun. Strategy of early screening for active pulmonary tuberculosis in general hospital[J]. Journal of Tuberculosis and Lung Disease , 2022, 3(4): 334-337. doi: 10.19983/j.issn.2096-8493.20220078

References 30

[1]	Golub JE, Dowdy DW. Screening for active tuberculosis: methodological challenges in implementation and evaluation. Int J Tuberc Lung Dis, 2013, 17(7): 856-865. doi: 10.5588/ijtld.13.0059. doi: 10.5588/ijtld.13.0059 pmid: 23743306
[2]	Uplekar M, Creswell J, Ottmani SE, et al. Programmatic approaches to screening for active tuberculosis. Int J Tuberc Lung Dis, 2013, 17(10):1248-1256. doi: 10.5588/ijtld.13.0199. doi: 10.5588/ijtld.13.0199 pmid: 24025375
[3]	World Health Organization. Global tuberculosis report 2021. Geneva:World Health Organization, 2021.
[4]	中华人民共和国国家卫生健康委员会.2021年中国卫生健康统计年鉴. 北京: 中国协和医科大学出版, 2019.
[5]	中华人民共和国国家卫生和计划生育委员会. WS 288—2017肺结核诊断. 2017-11-09.
[6]	中华医学会, 中华医学会杂志社, 中华医学会全科医学分会, 等. 肺结核基层诊疗指南(实践版·2018). 中华全科医师杂志, 18 (8): 718-722. doi: 10.3760/cma.j.issn.1671-7368.2019.08.003. doi: 10.3760/cma.j.issn.1671-7368.2019.08.003
[7]	Sousa GJB, Silva JCO, Queiroz TV, et al. Clinical and epidemiological features of tuberculosis in children and adolescents. Rev Bras Enferm, 2019, 72(5): 1271-1278. doi: 10.1590/0034-7167-2018-0172. doi: 10.1590/0034-7167-2018-0172 URL
[8]	Im JG, Itoh H, Shim YS, et al. Pulmonary tuberculosis: CT findings-early active disease and sequential change with antituberculous therapy. Radiology, 1993, 186(3): 653-660. doi: 10.1148/radiology.186.3.8430169. doi: 10.1148/radiology.186.3.8430169 pmid: 8430169
[9]	Kim WS, Moon WK, Kim IO, et al.Pulmonary tuberculosis in children: evaluation with CT. AJR Am J Roentgenol, 1997, 168(4):1005-1009. doi: 10.2214/ajr.168.4.9124105. doi: 10.2214/ajr.168.4.9124105 URL
[10]	Ko JM, Park HJ, Cho DG, et al. CT differentiation of tuberculous and non-tuberculous pleural infection, with emphasis on pulmonary changes. Int J Tuberc Lung Dis, 2015, 19(11): 1361-1368. doi: 10.5588/ijtld.15.0092. doi: 10.5588/ijtld.15.0092 pmid: 26467589
[11]	Yoshiyama T, Kurosaki A, Ogata H, et al. Limited benefit of CT scans in tuberculosis contact tracing. J Infect Chemother, 2019, 25(10): 764-768. doi: 10.1016/j.jiac.2019.03.023. doi: S1341-321X(18)30326-X pmid: 31101527
[12]	Chung KF, Pavord ID. Prevalence, pathogenesis, and causes of chronic cough. Lancet, 2008, 371(9621): 1364-1374. doi: 10.1016/S0140-6736(08)60595-4. doi: 10.1016/S0140-6736(08)60595-4 pmid: 18424325
[13]	Abbara A, Davidson RN, Medscape. Etiology and management of genitourinary tuberculosis. Nat Rev Urol, 2011, 8(12): 678-688. doi: 10.1038/nrurol.2011.172. doi: 10.1038/nrurol.2011.172 pmid: 22157940
[14]	Piersimoni C, Mustazzolu A, Iacobino A, et al.Pyrazinamide susceptibility testing: proposed new standard with the BACTEC^TM MGIT^TM 960 system Int J Tuberc Lung Dis, 2016, 20(12): 1677-1680. doi: 10.5588/ijtld.16.0360. doi: 10.5588/ijtld.16.0360 pmid: 27931346
[15]	Mustazzolu A, Iacobino A, Giannoni F, et al. Improved Bactec MGIT 960 Pyrazinamide Test Decreases Detection of False Mycobacterium tuberculosis Pyrazinamide Resistance. J Clin Microbiol, 2017, 55(12): 3552-3553. doi: 10.1128/JCM.01437-17. doi: 10.1128/JCM.01437-17 URL
[16]	Natarajan A, Beena PM, Devnikar AV, et al. A systemic review on tuberculosis. Indian J Tuberc, 2020, 67(3): 295-311. doi: 10.1016/j.ijtb.2020.02.005. doi: 10.1016/j.ijtb.2020.02.005 URL
[17]	Zhang Q, Zhang Q, Sun BQ, et al. GeneXpert MTB/RIF for rapid diagnosis and rifampin resistance detection of endobronchial tuberculosis. Respirology, 2018, 23(10): 950-955. doi: 10.1111/resp.13316. doi: 10.1111/resp.13316 pmid: 29691960
[18]	Pai M, Nathavitharana R. Extrapulmonary tuberculosis: new diagnostics and new policies. Indian J Chest Dis Allied Sci, 2014, 56(2): 71-73.
[19]	Zeka AN, Tasbakan S, Cavusoglu C. Evaluation of the GeneXpert MTB/RIF assay for rapid diagnosis of tuberculosis and detection of rifampin resistance in pulmonary and extrapulmonary specimens. J Clin Microbiol, 2011, 49(12): 4138-4141. doi: 10.1128/JCM.05434-11. doi: 10.1128/JCM.05434-11 URL
[20]	World Health Organization. Systematic screening for active tuberculosis: an operational guide.Geneva:World Health Organization, 2015.
[21]	张灿有, 陈彬, 叶建君, 等. 中国重点人群肺结核患病与发病调查分析. 中国防痨杂志, 2021, 43(12):1260-1268. doi: 10.3969/j.issn.1000-6621.2021.12.006. doi: 10.3969/j.issn.1000-6621.2021.12.006
[22]	Ohene SA, Bonsu F, Hanson-Nortey NN, et al. Provider initiated tuberculosis case finding in outpatient departments of health care facilities in Ghana: yield by screening strategy and target group. BMC Infect Dis, 2017, 17(1): 739. doi: 10.1186/s12879-017-2843-5. doi: 10.1186/s12879-017-2843-5 URL
[23]	World Health Organization. Global tuberculosis control: WHO report 2011. Geneva:World Health Organization, 2011.
[24]	中华人民共和国国家卫生健康委办公厅. 国家卫生健康委办公厅关于印发中国结核病预防控制工作技术规范(2020年版)的通知. 2020-04-02.
[25]	Basaraba RJ, Hunter RL. Pathology of Tuberculosis: How the Pathology of Human Tuberculosis Informs and Directs Animal Models. Microbiol Spectr, 2017, 5(3). doi: 10.1128/microbiolspec.TBTB2-0029-2016. doi: 10.1128/microbiolspec.TBTB2-0029-2016
[26]	Zhou G, Luo Q, Luo S, et al. Interferon-γ release assays or tuberculin skin test for detection and management of latent tuberculosis infection: a systematic review and meta-analysis. Lancet Infect Dis, 2020, 20(12): 1457-1469. doi: 10.1016/S1473-3099(20)30276-0. doi: 10.1016/S1473-3099(20)30276-0 URL
[27]	王艳, 房宏霞, 郑开巧, 等. 2018—2020年深圳市龙华区某综合医院呼吸科加强住院患者结核病病原学检查的效果分析. 中国防痨杂志, 2022, 44 (4): 368-374. doi: 10.19982/j.issn.1000-6621.20210682. doi: 10.19982/j.issn.1000-6621.20210682
[28]	Assefa D, Belachew F, Wondimagegn G, et al. Missed pulmonary tuberculosis: a cross sectional study in the general medical inpatient wards of a large referral hospital in Ethiopia. BMC Infect Dis, 2019, 19(1): 60. doi: 10.1186/s12879-019-3716-x. doi: 10.1186/s12879-019-3716-x pmid: 30654763
[29]	Kang W, Du J, Yang S, et al. The prevalence and risks of major comorbidities among inpatients with pulmonary tuberculosis in China from a gender and age perspective: a large-scale multicenter observational study. Eur J Clin Microbiol Infect Dis, 2021, 40(4): 787-800. doi: 10.1007/s10096-020-04077-2. doi: 10.1007/s10096-020-04077-2 URL
[30]	高磊, 张慧, 胡茂桂, 等. 基于多中心调查数据和空间统计模型的全国结核分枝杆菌潜伏感染率估算. 中国防痨杂志, 2022, 44 (1): 54-59. doi: 10.19982/j.issn.1000-6621.20210661. doi: 10.19982/j.issn.1000-6621.20210661